James A Hadley

Summary

Publications

  1. ncbi Cost-effective pharmacotherapy for inhalant allergic rhinitis
    James A Hadley
    Division of Otolaryngology Head and Neck Surgery, University of Rochester Medical Center, Rochester, NY 14618, USA
    Otolaryngol Clin North Am 36:825-36. 2003
  2. ncbi Rhinosinusitis: establishing definitions for clinical research and patient care
    Eli O Meltzer
    Department of Pediatrics, Allergy and Asthma Medical Group and Research Center, 9610 Granite Ridge Drive, Suite B, San Diego, CA 92123, USA
    J Allergy Clin Immunol 114:155-212. 2004
  3. ncbi Rhinosinusitis: Establishing definitions for clinical research and patient care
    Eli O Meltzer
    Allergy and Asthma Medical Group and Research Center, Department of Pediatrics, University of California, San Diego 92123, USA
    Otolaryngol Head Neck Surg 131:S1-62. 2004
  4. ncbi Pharmacological treatments for rhinosinusitis
    Farhan Taghizadeh
    University of Rochester Medical Center, 1065 Senator Keating Boulevard, Suite 210, Rochester, NY 14618, USA
    Expert Opin Pharmacother 3:305-13. 2002
  5. ncbi Oral beta-lactams in the treatment of acute bacterial rhinosinusitis
    James A Hadley
    University of Rochester Medical Center, Rochester, NY 14607, USA
    Diagn Microbiol Infect Dis 57:47S-54S. 2007
  6. ncbi Value of short-course antimicrobial therapy in acute bacterial rhinosinusitis
    James A Hadley
    Clinical Otolaryngology, University of Rochester Medical Center, Rochester, NY, USA
    Int J Antimicrob Agents 26:S164-9. 2005
  7. doi Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis
    James A Hadley
    Department of Otolaryngology Head and Neck Surgery, University of Rochester Medical Center, Rochester, New York, USA
    Laryngoscope 120:1057-62. 2010
  8. ncbi The efficacy of cefdinir in acute bacterial rhinosinusitis
    James A Hadley
    University of Rochester Medical Center, Rochester, NY, USA
    Expert Opin Pharmacother 7:1075-83. 2006
  9. ncbi Faropenem medoxomil: a treatment option in acute bacterial rhinosinusitis
    James A Hadley
    University Otolaryngology Associates, 2365 South Clinton Avenue, Rochester, NY 14618, USA
    Expert Rev Anti Infect Ther 4:923-37. 2006
  10. ncbi Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology
    Michael S Benninger
    Department of Otolaryngology Head and Neck Surgery, Henry Ford Hospital, Detroit, MI 48202, USA
    Otolaryngol Head Neck Surg 129:S1-32. 2003

Detail Information

Publications18

  1. ncbi Cost-effective pharmacotherapy for inhalant allergic rhinitis
    James A Hadley
    Division of Otolaryngology Head and Neck Surgery, University of Rochester Medical Center, Rochester, NY 14618, USA
    Otolaryngol Clin North Am 36:825-36. 2003
    ..Patients with only sporadic problems in season or on limited exposure are best treated with oral antihistamines, topical cromolyn, and short-term decongestant therapy...
  2. ncbi Rhinosinusitis: establishing definitions for clinical research and patient care
    Eli O Meltzer
    Department of Pediatrics, Allergy and Asthma Medical Group and Research Center, 9610 Granite Ridge Drive, Suite B, San Diego, CA 92123, USA
    J Allergy Clin Immunol 114:155-212. 2004
  3. ncbi Rhinosinusitis: Establishing definitions for clinical research and patient care
    Eli O Meltzer
    Allergy and Asthma Medical Group and Research Center, Department of Pediatrics, University of California, San Diego 92123, USA
    Otolaryngol Head Neck Surg 131:S1-62. 2004
  4. ncbi Pharmacological treatments for rhinosinusitis
    Farhan Taghizadeh
    University of Rochester Medical Center, 1065 Senator Keating Boulevard, Suite 210, Rochester, NY 14618, USA
    Expert Opin Pharmacother 3:305-13. 2002
    ..Allergic fungal rhinosinusitis results from a hypersensitivity reaction to demetiaceous fungi. Cure of the effects of rhinosinusitis depends on the establishment of a healthy sinus cycle...
  5. ncbi Oral beta-lactams in the treatment of acute bacterial rhinosinusitis
    James A Hadley
    University of Rochester Medical Center, Rochester, NY 14607, USA
    Diagn Microbiol Infect Dis 57:47S-54S. 2007
    ..Clinicians are encouraged to consider the local pathogen distribution and rates of antibacterial resistance in selecting therapy for ABRS...
  6. ncbi Value of short-course antimicrobial therapy in acute bacterial rhinosinusitis
    James A Hadley
    Clinical Otolaryngology, University of Rochester Medical Center, Rochester, NY, USA
    Int J Antimicrob Agents 26:S164-9. 2005
    ..High single-dose therapy has the potential to maximize adherence to prescribed therapy and thus to help in the battle to control rising antibiotic resistance among respiratory pathogens...
  7. doi Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis
    James A Hadley
    Department of Otolaryngology Head and Neck Surgery, University of Rochester Medical Center, Rochester, New York, USA
    Laryngoscope 120:1057-62. 2010
    ..To evaluate the efficacy and safety of moxifloxacin in the treatment of acute bacterial rhinosinusitis (ABRS)...
  8. ncbi The efficacy of cefdinir in acute bacterial rhinosinusitis
    James A Hadley
    University of Rochester Medical Center, Rochester, NY, USA
    Expert Opin Pharmacother 7:1075-83. 2006
    ....
  9. ncbi Faropenem medoxomil: a treatment option in acute bacterial rhinosinusitis
    James A Hadley
    University Otolaryngology Associates, 2365 South Clinton Avenue, Rochester, NY 14618, USA
    Expert Rev Anti Infect Ther 4:923-37. 2006
    ..Faropenem medoxomil has almost no drug-drug interactions and little requirement for dosage adjustments in the typical acute rhinosinusitis population...
  10. ncbi Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology
    Michael S Benninger
    Department of Otolaryngology Head and Neck Surgery, Henry Ford Hospital, Detroit, MI 48202, USA
    Otolaryngol Head Neck Surg 129:S1-32. 2003
  11. ncbi Rhinosinusitis: developing guidance for clinical trials
    Eli O Meltzer
    Allergy and Asthma Medical Group and Research Center and Department of Pediatrics, University of California, San Diego, USA
    J Allergy Clin Immunol 118:S17-61. 2006
    ....
  12. ncbi Rhinosinusitis: Developing guidance for clinical trials
    Eli O Meltzer
    Allergy and Asthma Medical Group and Research Center Department of Pediatrics, University of California, San Diego, San Diego, California
    Otolaryngol Head Neck Surg 135:S31-80. 2006
    ....
  13. ncbi Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis
    Berrylin J Ferguson
    University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
    Otolaryngol Head Neck Surg 131:207-14. 2004
    ..To compare the clinical and bacteriologic efficacy and safety of short-duration treatment with telithromycin given for 5 days with moxifloxacin given for 10 days in adults with acute bacterial rhinosinusitis (ABRS)...
  14. ncbi Antimicrobial treatment guidelines for acute bacterial rhinosinusitis
    Jack B Anon
    University of Pittsburgh, School of Medicine, USA
    Otolaryngol Head Neck Surg 130:1-45. 2004
  15. ncbi Endoscopically directed middle meatal cultures versus maxillary sinus taps in acute bacterial maxillary rhinosinusitis: a meta-analysis
    Michael S Benninger
    Department of Otolaryngology Head and Neck Surgery, Henry Ford Hospital, Detroit, MI, USA
    Otolaryngol Head Neck Surg 134:3-9. 2006
    ..The aim of this study was to verify the correlation of endoscopically directed middle meatal (EDMM) cultures with maxillary sinus tap and culture (MST) in acute bacterial rhinosinusitis (ABRS)...
  16. ncbi Techniques of intranasal steroid use
    Michael S Benninger
    Department of Otolaryngology Head and Neck Surgery, Henry Ford Hospital, Detroit, Michigan 48202, USA
    Otolaryngol Head Neck Surg 130:5-24. 2004
    ..To determine whether the technique used affects the efficacy and safety of the product, this review of evidence had the goal of identifying and establishing a preferred method of applying INS sprays...
  17. ncbi Diagnosing acute bacterial rhinosinusitis
    Micheal S Benninger
    Arch Intern Med 164:568-70; author reply 570. 2004
  18. ncbi The Cooperative Outcomes Group for ENT: a multicenter prospective cohort study on the effectiveness of medical and surgical treatment for patients with chronic rhinosinusitis
    David L Witsell
    Duke University Medical Center, Divison of Otolaryngology Head and Neck Surgery, Durham Veterans Administration Medical Center, NC 27710, USA
    Otolaryngol Head Neck Surg 132:171-9. 2005
    ..To assess outcomes for patients with chronic rhinosinusitis...